title: [Ciprofloxacin in the treatment of respiratory infections].
abstract: The authors evaluate the clinical efficacy and tolerability of the new wide-spectrum fluoroquinolone ciprofloxacin for management of respiratory tract infections. Of the 20 patients enrolled and treated with 500 mg ciprofloxacin tablets twice daily, 17 (85%) were completely cured, and tolerance was excellent in 19 (95%).
authors: Divisione di Medicina, Ospedale S. Giovanni E. di Tivoli.
authors: F
authors: F
authors: Poggi
authors: F
authors: F
authors: Tognazzi
authors: M
authors: M
authors: Doddi
authors: A
authors: A
authors: Lauri
authors: C
authors: C
authors: Placidi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D002939:Ciprofloxacin
vernacular_title: La ciprofloxacina nel trattamento delle infezioni respiratorie.